In order to determine requirements for handling identifiers, I would prefer to work with real live data rather than being forced to blue-sky it. At this point, we have to produce a Working paper on Identifiers. The problem remains that we still don't have any idea what identifiers people use in the real world on the ISA or GS, and how they might relate to those used within the application transaction on the NM1 and REF segments.
I'm sure none of us is daunted by the prospect of analysis - but we have to have *something* to analyze. I am urging payers and large providers, especially, to share technical details with us. For example, tell us what IDs you prefer to be addressed by (e.g., the NAIC) and their values. Tell us how you identify your trading partners on the ISA and in the application. What Clearinghouses do you use? What are your CH's addressing requirements? Can you share an extract of your trading partner file which not only includes these IDs, but basic demographics (Provider taxonomy code, basic name, address, EDI contact, etc.)? Can you share your HIPAA IG companion guides, also? C'mon, it isn't exactly a state secret to say I require providers to address interchanges with NAIC co-code XXXXX and that I use CH A and B. Or that I have the TIN for my providers, which if push came to shove, I could use as the receiver ID. None of this should be especially sensitive information, though I respect your concern - if any - in sharing this stuff. Please write or call me privately so that we can discuss how any information you share will be used in the analysis, and who would have access to it. William J. Kammerer Novannet, LLC. +1 (614) 487-0320
